Theraflu Severe Cold Relief Nighttime Powder, For Solution
NDC Package 0067-0101-06
Package Information
Theraflu Severe Cold Relief Nighttime (acetaminophen, diphenhydramine hcl) powders is • do not use more than directed• take every 4 hours, while symptoms persist. This formulation utilizes a powder, for solution delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0067-0101 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2670598 - acetaminophen 500 MG / dextromethorphan hydrobromide 20 MG Powder for Oral Solution
- RxCUI: 2670598 - APAP 500 MG / dextromethorphan hydrobromide 20 MG Powder for Oral Solution
- RxCUI: 2670677 - acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG Powder for Oral Solution
- RxCUI: 2670677 - acetaminophen 650 MG / diphenhydramine hydrochloride 25 MG Powder for Oral Solution
- RxCUI: 2670677 - acetaminophen 650 MG / diphenhydramine HCl 25 MG Granules for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0067 - Haleon Us Holdings Llc
- 0067-0101 - Theraflu Severe Cold Relief Nighttime
- 0067-0101-06 - 6 PACKET in 1 CARTON / 1 POWDER, FOR SOLUTION in 1 PACKET
- 0067-0101 - Theraflu Severe Cold Relief Nighttime
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0067-0101-06 identifies a specific commercial package of 6 packet in 1 carton / 1 powder, for solution in 1 packet of Theraflu Severe Cold Relief Nighttime, a human over the counter drug labeled by Haleon Us Holdings Llc. This powder, for solution is formulated for oral use and contains acetaminophen; diphenhydramine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on December 01, 2023. The current certification is valid through December 31, 2026.
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00067010106. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.